Loading insider details...
Beta
Latest Form 4 (Aug 6, 2026): Grant/Award of 1,598 ATEX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 6, 2026 | Anterix Inc. (ATEX) | Grant/Award | 1,598 | n/a |
| Aug 7, 2025 | Anterix Inc. (ATEX) | Grant/Award | 7,767 | n/a |
| Dec 10, 2024 | Anterix Inc. (ATEX) | Grant/Award | 5,002 | n/a |
| Aug 22, 2024 | PYXUS INTERNATIONAL, INC. (PYYX) | Purchase | 811,150 | $2.03M |
| Jun 20, 2024 | PYXUS INTERNATIONAL, INC. (PYYX) | Purchase | 325,374 | $911.0K |
| Jun 13, 2024 | PYXUS INTERNATIONAL, INC. (PYYX) | Purchase | 123,544 | $345.9K |
| Feb 12, 2024 | Anterix Inc. (ATEX) | Grant/Award | 2,647 | n/a |
| Oct 10, 2023 | Constellation Acquisition Corp I (CSTA) | Sale | 250,000 | $2.72M |
| Oct 5, 2023 | Estrella Immunopharma, Inc. (UPTD) | Other (see footnotes) | 255,000 | $2.77M |
| Sep 26, 2023 | Kairous Acquisition Corp. Ltd (KACL) | Sale | 100,000 | $1.12M |